Company intelligence / Profile preview
Epsilon Molecular Engineering
Saitama City/Sakura-ku/Shimo-okubo, Saitama, Japanepsilon-mol.co.jp ↗
- Ownership
- Private
- Employees
- ~15
- Development stage
- Preclinical
01
Overview
Epsilon Molecular Engineering has developed proprietary high-diversity VHH and cyclic peptide libraries using cDNA display technology. Their high-throughput screening enables rapid identification of stable and functional biomolecules. The company’s pipeline includes multiple programs at the discovery or preclinical stage targeting unmet medical needs such as nonalcoholic steatohepatitis, ALS, pancreatic cancer, Alzheimer’s disease, inflammation, and infectious diseases like COVID‑19. No clinical results have been published yet.
- Therapeutic areas
- GastroenterologyImmunologyOncologyNeurologyInfectious Diseases
- Modalities
- Nanobody therapy (VHH antibody)Peptide aptamerMonoclonal antibodyCyclic peptideSmall molecule
- Industry
- Biotech
02
Drug pipeline
16 assets15 more assets in the full pipeline.
Request access →03
Partnerships
Joint research collaborations on COVID‑19 and other indications; specific partners not publicly named.
Beyond the preview
Go deeper on Epsilon Molecular Engineering.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Epsilon Molecular Engineering.